Filter
4603
Filtered Results: 4603
Text search:
Pregnancy
Featured
Recommendations
387
New Publications
1496
Language
Document type
No document type
3031
Guidelines
553
Studies & Reports
501
Manuals
147
Fact sheets
111
Strategic & Response Plan
93
Training Material
69
Infographics
33
Situation Updates
22
Brochures
20
Resource Platforms
11
Videos
7
Online Courses
3
App
2
Countries / Regions
India
273
Kenya
167
Ethiopia
135
Nepal
132
Global
125
South Africa
118
Uganda
110
Sierra Leone
108
Nigeria
101
Zambia
100
Tanzania
98
Malawi
92
Rwanda
90
Liberia
88
Bangladesh
86
Myanmar / Burma
61
Ghana
57
Philippines
53
Latin America and the Carribbean
53
Namibia
50
Western and Central Europe
48
Lesotho
44
Zimbabwe
42
Cambodia
38
Senegal
37
Indonesia
37
Africa
37
Congo, Democratic Republic of
33
Syria
32
Ukraine
31
Haiti
29
Brazil
29
Botswana
29
Germany
28
Russia
27
South–East Asia Region
23
South Sudan
22
Mozambique
22
Burkina Faso
21
Eswatini/ Swaziland
21
Asia
18
Eastern Europe
17
Guinea
16
Venezuela
16
Cameroon
14
Afghanistan
12
Colombia
12
East and Southern Africa
12
Pakistan
11
Benin
10
Yemen
10
Middle East and North Africa
10
Eastern Europe and Central Asia
9
West and Central Africa
8
USA
7
Madagascar
7
Paraguay
7
Somalia
6
Lebanon
6
Thailand
6
Western Pacific Region
6
Mali
5
Argentina
5
Albania
5
North America
5
Côte d’Ivoire / Ivory Coast
4
Turkey
4
Sudan
4
Peru
4
Bolivia
4
Sri Lanka
4
Southern Africa
4
Laos
4
Tajikistan
4
Georgia
4
Vietnam
4
Togo
3
Jordan
3
Papua New Guinea
3
Burundi
3
Iraq
2
Central African Republic
2
North Macedonia
2
Honduras
2
Ecuador
2
Angola
2
Guatemala
2
Mexico
2
Fiji
2
Bhutan
2
Palestine
2
Moldova
2
Egypt
1
Gambia
1
Ireland
1
Dominican Republic
1
Switzerland
1
El Salvador
1
Greece
1
Libya
1
Chile
1
Other region
1
Solomon Islands
1
Armenia
1
Mongolia
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Lithuania
1
Kyrgyzstan
1
Jamaica
1
France
1
United Kingdom
1
Spain
1
Belarus
1
Latvia
1
United Arab Emirates
1
Authors & Publishers
Publication Years
Category
Countries
2179
Women & Child Health
436
Clinical Guidelines
433
Public Health
179
Capacity Building
123
Key Resources
83
Pharmacy & Technologies
19
Annual Report MEDBOX
1
Toolboxes
HIV
456
COVID-19
281
Mental Health
242
Zika
124
TB
121
Caregiver
119
Refugee
115
Disability
101
Ebola
78
Conflict
78
Rapid Response
76
NCDs
75
Pharmacy
64
NTDs
62
Planetary Health
60
Global Health Education
46
AMR
30
Natural Hazards
25
Health Financing Toolbox
21
Specific Hazards
13
Cholera
11
Polio
7
Social Ethics
7
South Sudan
1
Typhoon
1
Health Financing
1
Training aids
Evidence shows that FGM can cause several physical, mental and sexual health complications in girls and women, and in newborns. Health-care providers play an important role in supporting girls and women living with FGM, and improving their health and well-being. They are in a uniqu...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
• Leptospirosis is a disease that is caused by
spirochete bacteria in the genus Leptospira.
There are 10 pathogenic species, and more
than 250 pathogenic serovars.
• While leptospirosis occurs worldwide, it is
more common in tropical or sub-tropical
climates.
The purpose of this guide is to provide practical advice for health staff undertaking infectious disease preparedness and response activities to ensure that access to safe abortion care (SAC) is maintained when an infectious disease outbreak occurs. It is an operational guide which can serve to supp...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health of refugees and migrants at the seventy-second World Health Assembly, in May 2019.
The updates are based on evidence emerging from the: Ongoing monitoring of the disease. Protection that the population already developed against COVID-19 through previous infection or vaccination. Epidemiological situation, availability of diagnostic tests and access to therapeutic options.
Obesity in all age groups, including children and adolescents, is a public health challenge across all settings. Obesity is now classified as a complex multifactorial chronic disease and not just a risk factor for other noncommunicable diseases and comorbidities. Recognizing the significance of prim...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
This publication articulates the WHO Botswana Country Office’s focus and investment needs for the biennium 2022–2023, building on achievements, networks, and partnerships fostered in 2020-2021.
As the leading health authority within the United Nations system in Botswana, the WHO Country Offi...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
